GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Koninklijke Philips NV (XAMS:PHIA) » Definitions » Capex-to-Revenue

Koninklijke Philips NV (XAMS:PHIA) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Koninklijke Philips NV Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Koninklijke Philips NV's Capital Expenditure for the three months ended in Dec. 2023 was €0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was €5,062.00 Mil.

Hence, Koninklijke Philips NV's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.00.


Koninklijke Philips NV Capex-to-Revenue Historical Data

The historical data trend for Koninklijke Philips NV's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Koninklijke Philips NV Capex-to-Revenue Chart

Koninklijke Philips NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.05 0.04 0.05 0.04

Koninklijke Philips NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Koninklijke Philips NV's Capex-to-Revenue

For the Medical Devices subindustry, Koninklijke Philips NV's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Koninklijke Philips NV's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's Capex-to-Revenue falls into.



Koninklijke Philips NV Capex-to-Revenue Calculation

Koninklijke Philips NV's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-644) / 18169
=0.04

Koninklijke Philips NV's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 5062
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Koninklijke Philips NV  (XAMS:PHIA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Koninklijke Philips NV Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Koninklijke Philips NV's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Koninklijke Philips NV (XAMS:PHIA) Business Description

Address
Philips Center, Amstelplein 2, Amsterdam, NLD, 1096 BC
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.

Koninklijke Philips NV (XAMS:PHIA) Headlines

No Headlines